Arexvy Impfung

RSV Vaccine Approved: Arexvy Offers Protection for Seniors

What is Arexvy and What is it Used For?

Arexvy is a vaccine for adults 60 years of age and older to protect them against lower respiratory tract disease (LRTD), such as bronchitis or pneumonia, caused by respiratory syncytial virus (RSV).

First RSV Vaccine Approved

In June 2023, Arexvy became the first vaccine to be approved by the European Medicines Agency (EMA) for the prevention of RSV disease.